Skip to content

Effect of Nutri-PEITC jelly on carcinogen detoxification in smokers: a pre-post clinical trial

Effect of Nutri-PEITC jelly on carcinogen detoxification in smokers: a pre-post clinical trial

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210519003
Enrollment
30
Registered
2021-05-19
Start date
2020-12-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy male regular smokers. tobacco-related carcinogen detoxification

Interventions

Oral intake of 4 cups of Nutri-PEITC jelly per day for 3 consecutive days
Experimental Dietary Supplement

Sponsors

Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Thai men aged 20-60 years, 2. No systemic disease that cannot be controlled or untreated, 3. Smoking 5-45 cigarettes per day for 1-10 years, 4. No history of psychiatric disorders, 5. Use only cigarettes (no other narcotics), 6. No medications affecting cytochrome P450 1A2, 2A6 and 2A13 such as antidepressants, antihypertensive drugs, calcium channel blockers such as varapamil. Beta blockers such as propranolol, anticoagulants such as warfarin and tricloidine, antibiotics such as ciprofloxacin and fluoroquinolores, and opioid analgesic drugs, 7. BMI between 18-30 kg/ m2, 8. Normal blood laboratory tests include kidney function (BUN, creatinine), liver function (AST, ALT, total bilirubin), blood lipid levels, normal blood sugar levels and complete blood count, 9. Able to communicate well and give informed consent in writing, 10. Able to consume Nutri-PEITC jelly, 11. Able to avoid eating cruciferous vegetables such as watercress, kale, cabbage, broccoli, Chinese cabbage, cauliflower, radishes, mustard, and wasabi, 12. Able to avoid drinking alcoholic beverages at least 24 hours before enrolling in the study and throughout the study period.

Exclusion criteria

Exclusion criteria: 1. Having cancer or a history of cancer, 2. Having liver or kidney diseases, 3. Taking paracetamol, chlorazone (ChlorzOXaZone) and Enceasein (N-acetylcysteine) within 24 hours before participating in the study and throughout the study period.)

Design outcomes

Primary

MeasureTime frame
changes in NNAL metabolites in urine before and after 3 days of intervention LC-MS/MS,Adverse events after 3 days of intervention observation of adverse event, subject diaries

Secondary

MeasureTime frame
changes in NNN metabolites in urine before and after 3 days of intervention LC-MS/MS analysis

Countries

Thailand

Contacts

Public ContactDunyaporn Trachootham

Mahidol University

dunyaporn.tra@mahidol.edu66846953647

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026